Circadian System. Advances in Protein Chemistry and Structural Biology Volume 137

Table of Contents

1. The circadian systems genes and their importance of human health
S. Pehlivan

2. Single nucleotide polymorphisms (SNPs) in circadian genes: Impact on gene function and phenotype
Ibrahim Baris, Onur Ozcan, and Ibrahim Halil Kavakli

3. The impact of biological clock and sex hormones on the risk of disease
Andr� Furtado, Diana Costa, Manuel C. Lemos, J. Eduardo Cavaco, Cec�lia R.A. Santos, and Telma Quintela

4. Advances in circadian clock regulation of reproduction
Yating Li, Haisen Zhang, Yiqun Wang, Dan Li, and Huatao Chen

5. Circadian rhythms and cancer
Chandrabose Selvaraj, Sher Zaman Safi, and Rajendran Vijayakumar

6. Molecular characterization of circadian gene expression and its correlation with survival percentage in colorectal cancer patients
Ankur Datta, Hephzibah Cathryn R., S. Udhaya Kumar, Karthick Vasudevan, D. Thirumal Kumar, Hatem Zayed, and C. George Priya Doss

7. Identification of potential circadian genes and associated pathways in colorectal cancer
progression and prognosis using microarray gene expression analysis
Sri Hari S., Keerthana G., Hrituraj Dey, Rahul V. Sangoji, D. Thirumal Kumar, Hatem Zayed, Karthick Vasudevan, and C. George Priya Doss

8. The role of environmental signals in the expression of rhythmic cardiac proteins and their influence on cardiac pathologies
Ana Beatriz Rezende Paula, Let�cia Teresinha Resende, Isabela Alc�ntara Barretto Ara�jo Jardim, Alexandre Martins Oliveira Portes, and Mauro C�sar Isoldi

9. Circadian system microRNAs Role in the development of cardiovascular diseases
Ivana Skrlec

10. The circadian system and mood related behavior in mice
U. Albrecht

11. The interplay between circadian clock and viral infections: A molecular perspective
Elora Kalita, Mamta Panda, and Vijay Kumar Prajapati

Authors

Rossen Donev Head of Research, MicroPharm Limited, UK. Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.